Breast screening, prognostic factors and survival--results from the Swedish two county study
- PMID: 1764377
- PMCID: PMC1977849
- DOI: 10.1038/bjc.1991.477
Breast screening, prognostic factors and survival--results from the Swedish two county study
Abstract
The results of the Swedish two-county study are analysed with respect to tumour size, nodal status and malignancy grade, and the relationship of these prognostic factors to screening and to survival. It is shown that these factors can account for much of the differences in survival between incidence screen detected, interval and control group cancers but to a lesser extent for cancers detected at the prevalence screen where length bias is greatest. Furthermore, examination of the relationships among the prognostic factors and mode of detection indicates that malignancy grade, as a measure of inherent malignant capacity, evolves as a tumour grows. The proportion of cancers with poor malignancy grade is several fold lower for cancers of diameter less than 15 cm than for cancers greater than 30 cm, independent of the length bias of screening. The implications of these findings for screening frequency are briefly discussed.
Similar articles
-
Update of the Swedish two-county program of mammographic screening for breast cancer.Radiol Clin North Am. 1992 Jan;30(1):187-210. Radiol Clin North Am. 1992. PMID: 1732926 Clinical Trial.
-
Prognostic importance of palpability as a feature of screen-detected breast cancers.J Med Screen. 2006;13(2):98-101. doi: 10.1258/096914106777589560. J Med Screen. 2006. PMID: 16792834
-
Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology.J Med Screen. 1995;2(2):94-8. doi: 10.1177/096914139500200208. J Med Screen. 1995. PMID: 7497163 Clinical Trial.
-
Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.APMIS. 2014 Aug;122(8):699-707. doi: 10.1111/apm.12294. APMIS. 2014. PMID: 25046200 Review.
-
Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50-69.Eur J Cancer Prev. 2012 Nov;21(6):499-506. doi: 10.1097/CEJ.0b013e328350b0f4. Eur J Cancer Prev. 2012. PMID: 22273849 Review.
Cited by
-
Aggressiveness of breast cancers detected by screening.BMJ. 1992 May 23;304(6838):1377-8. doi: 10.1136/bmj.304.6838.1377-b. BMJ. 1992. PMID: 1611345 Free PMC article. No abstract available.
-
Radiological audit of interval breast cancers: Estimation of tumour growth rates.Breast. 2020 Jun;51:114-119. doi: 10.1016/j.breast.2020.03.006. Epub 2020 Apr 1. Breast. 2020. PMID: 32298962 Free PMC article.
-
Survival and reduction in mortality from breast cancer. Impact of mammographic screening is not clear.BMJ. 2000 Dec 9;321(7274):1470; author reply 1471-2. BMJ. 2000. PMID: 11187946 Free PMC article. No abstract available.
-
Breast cancer screening: evidence of benefit depends on the method used.BMC Med. 2012 Dec 12;10:163. doi: 10.1186/1741-7015-10-163. BMC Med. 2012. PMID: 23234249 Free PMC article.
-
A study of interval breast cancer within the NHS breast screening programme.J Clin Pathol. 2000 Feb;53(2):140-6. doi: 10.1136/jcp.53.2.140. J Clin Pathol. 2000. PMID: 10767831 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical